Showing results (831-840 of 1,296) with videos related to
Sort By:
Pageof 130
Nature Reviews. Drug Discovery|October 4, 2006
Novel pharmacological targets for the treatment of Parkinson's diseaseAnthony H V Schapira, Erwan Bezard, Jonathan Brotchie, et al.Nature Reviews. Drug Discovery|December 17, 2008
Chemokine receptor antagonists: overcoming developmental hurdlesRichard HorukNature Reviews. Drug Discovery|January 1, 2009
Is NF-kappaB a good target for cancer therapy? Hopes and pitfallsVéronique Baud, Michael KarinNature Reviews. Drug Discovery|January 1, 2009
Transient receptor potential channels: targeting pain at the sourceArdem Patapoutian, Simon Tate, Clifford J WoolfNature Reviews. Drug Discovery|August 2, 2008
The nociceptin/orphanin FQ receptor: a target with broad therapeutic potentialDavid G LambertNature Reviews. Drug Discovery|August 2, 2007
Modelling of the blood-brain barrier in drug discovery and developmentRomeo Cecchelli, Vincent Berezowski, Stefan Lundquist, et al.Nature Reviews. Drug Discovery|August 2, 2007
Peroxynitrite: biochemistry, pathophysiology and development of therapeuticsCsaba Szabó, Harry Ischiropoulos, Rafael RadiNature Reviews. Drug Discovery|July 1, 2008
Creating and evaluating genetic tests predictive of drug responseScott T Weiss, Howard L McLeod, David A Flockhart, et al.Nature Reviews. Drug Discovery|December 2, 2008
End of the line for cannabinoid receptor 1 as an anti-obesity target?Dan JonesNature Reviews. Drug Discovery|July 24, 2007
Small-molecule therapies for cardiac hypertrophy: moving beneath the cell surfaceTimothy A McKinsey, David A KassPageof 130